Asacol® (mesalamine) is a prescription medication licensed to reduce inflammation caused by ulcerative colitis. There is only one form and strength of Asacol -- 400-mg delayed-release tablets.
Who makes this drug? Asacol is manufactured by Procter & Gamble Pharmaceuticals. At this time, Asacol is protected by patents that prevent any other company from making a generic version of this drug. However, if you search the Internet for "generic Asacol," you will find a number of companies selling it. The fact is that these medicines could be fake and/or potentially dangerous -- anything claiming to be "generic Asacol" should be avoided until an approved generic is available.
The patent for Asacol currently expires in July 2013. This is the earliest possible date that a generic version of Asacol could become available.
(Click Asacol to learn more about this drug, with information on who can take it, general safety precautions, and what to expect during treatment.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Asacol [package insert]. Rockaway, NJ: Warner Chilcott (US), LLC;2013 October.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed July 1, 2013.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia (PA): Lippincott Williams & Wilkins;2005.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 18, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click